In patients with aortic stenosis increased flow-mediated dilation is independently associated with higher peak jet velocity and lower asymmetric dimethylarginine levels

American Heart Journal

Volumn 161, Issue 5, 2011, Pages 893-899

  Schumm, Julia ^a   Luetzkendorf, Stephanie ^a   Rademacher, Wilma ^a   Franz, Marcus ^a   Schmidt Winter, Christiane ^a   Kiehntopf, Michael ^a   Figulla, Hans R ^a   Brehm, Bernhard R ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE;

AGED; AORTA STENOSIS; ARTERY BLOOD FLOW; ARTERY DILATATION; ARTICLE; BLOOD FLOW VELOCITY; BRACHIAL ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIAL DYSFUNCTION; FEMALE; FLOW MEDIATED DILATION; HUMAN; MALE; PEAK JET VELOCITY; PRIORITY JOURNAL; PULSE PRESSURE;

AGED; AORTIC VALVE STENOSIS; ARGININE; BLOOD FLOW VELOCITY; BLOOD PRESSURE; BRACHIAL ARTERY; DILATATION, PATHOLOGIC; ECHOCARDIOGRAPHY; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; NITRIC OXIDE SYNTHASE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; ULTRASONOGRAPHY, DOPPLER;

EID: 79955892899     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2011.02.015     Document Type: Article

References (45)

1. D.S. Celermajer, K.E. Sorensen, and D. Georgakopoulos Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults Circulation 88 5 Pt 1 1993 2149 2155 (Pubitemid 23326094)
2. D.S. Celermajer, K.E. Sorensen, and D.J. Spiegelhalter Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women J Am Coll Cardiol 24 1994 471 476 (Pubitemid 24246550)
3. J.A. Panza, A.A. Quyyumi, and J.E. Brush Jr Abnormal endothelium- dependent vascular relaxation in patients with essential hypertension N Engl J Med 323 1990 22 27 (Pubitemid 20209468)
4. D. Ardigo, L. Franzini, and S. Valtuena Relation of plasma insulin levels to forearm flow-mediated dilatation in healthy volunteers Am J Cardiol 97 2006 1250 1254
5. C.M. Otto, I.G. Burwash, and M.E. Legget Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome Circulation 95 1997 2262 2270 (Pubitemid 27191003)
6. M. Olsson, J. Thyberg, and J. Nilsson Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves Arterioscler Thromb Vasc Biol 19 1999 1218 1222 (Pubitemid 29227640)
7. M. Olsson, C.J. Dalsgaard, and A. Haegerstrand Accumulation of T lymphocytes and expression of interleukin-2 receptors in nonrheumatic stenotic aortic valves J Am Coll Cardiol 23 1994 1162 1170 (Pubitemid 24117151)
8. L.L. Demer Cholesterol in vascular and valvular calcification Circulation 104 2001 1881 1883 (Pubitemid 32983227)
9. E.R. Mohler III, F. Gannon, and C. Reynolds Bone formation and inflammation in cardiac valves Circulation 103 2001 1522 1528 (Pubitemid 32226259)
10. R. Ross Atherosclerosis-an inflammatory disease N Engl J Med 340 1999 115 126
11. A.D. Baron Vascular reactivity Am J Cardiol 84 1999 25J 27J (Pubitemid 29334857)
12. D.S. Celermajer Endothelial dysfunction: does it matter? Is it reversible? J Am Coll Cardiol 30 1997 325 333 (Pubitemid 27339309)
13. D.S. Celermajer, K.E. Sorensen, and V.M. Gooch Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis Lancet 340 1992 1111 1115
14. A.E. Donald, J.P. Halcox, and M. Charakida Methodological approaches to optimize reproducibility and power in clinical studies of flow-mediated dilation J Am Coll Cardiol 51 2008 1959 1964 (Pubitemid 351636449)
15. A. Mazzone, L. Venneri, and S. Berti Aortic valve stenosis and coronary artery disease: pathophysiological and clinical links J Cardiovasc Med (Hagerstown) 8 2007 983 989 (Pubitemid 351339554)
16. E. Poggianti, L. Venneri, and V. Chubuchny Aortic valve sclerosis is associated with systemic endothelial dysfunction J Am Coll Cardiol 41 2003 136 141 (Pubitemid 36044415)
17. S.H. Goldbarg, S. Elmariah, and M.A. Miller Insights into degenerative aortic valve disease J Am Coll Cardiol 50 2007 1205 1213 (Pubitemid 47405136)
18. Y. Matsumoto, V. Adams, and C. Walther Reduced number and function of endothelial progenitor cells in patients with aortic valve stenosis: a novel concept for valvular endothelial cell repair Eur Heart J 30 2009 346 355
19. R. Rosenhek, R. Zilberszac, and M. Schemper Natural history of very severe aortic stenosis Circulation 121 2010 151 156
20. M.C. Corretti, T.J. Anderson, and E.J. Benjamin Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force J Am Coll Cardiol 39 2002 257 265 (Pubitemid 34084631)
21. N. Gokce, M. Holbrook, and L.M. Hunter Acute effects of vasoactive drug treatment on brachial artery reactivity J Am Coll Cardiol 40 2002 761 765 (Pubitemid 34925624)
22. P. Kleinbongard, R. Schulz, and T. Rassaf Red blood cells express a functional endothelial nitric oxide synthase Blood 107 2006 2943 2951
23. W.H. Ding, Y.Y. Lam, and A. Duncan Predictors of survival after aortic valve replacement in patients with low-flow and high-gradient aortic stenosis Eur J Heart Fail 11 2009 897 902
24. A. Pasipoularides Complementarity and competitiveness of the intrinsic and extrinsic components of the total ventricular load: demonstration after valve replacement in aortic stenosis Am Heart J 153 2007 4 6 (Pubitemid 44880889)
25. A. Pasipoularides Clinical assessment of ventricular ejection dynamics with and without outflow obstruction J Am Coll Cardiol 15 1990 859 882 (Pubitemid 20101580)
26. A. Nemes, T.W. Galema, and M.L. Geleijnse Aortic valve replacement for aortic stenosis is associated with improved aortic distensibility at long-term follow-up Am Heart J 153 2007 147 151 (Pubitemid 44880890)
27. J. Yeboah, A.R. Folsom, and G.L. Burke Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis Circulation 120 2009 502 509
28. M. Guazzi, M. Samaja, and R. Arena Long-term use of sildenafil in the therapeutic management of heart failure J Am Coll Cardiol 50 2007 2136 2144 (Pubitemid 350117342)
29. Y. Kitta, J.E. Obata, and T. Nakamura Persistent impairment of endothelial vasomotor function has a negative impact on outcome in patients with coronary artery disease J Am Coll Cardiol 53 2009 323 330
30. R. Chenevard, M. Bechir, and D. Hurlimann Persistent endothelial dysfunction in calcified aortic stenosis beyond valve replacement surgery Heart 92 2006 1862 1863 (Pubitemid 44851346)
31. T. Peltonen, P. Taskinen, and J. Napankangas Increase in tissue endothelin-1 and ETA receptor levels in human aortic valve stenosis Eur Heart J 30 2009 242 249
32. M. Briand, J.G. Dumesnil, and L. Kadem Reduced systemic arterial compliance impacts significantly on left ventricular afterload and function in aortic stenosis: implications for diagnosis and treatment J Am Coll Cardiol 46 2005 291 298 (Pubitemid 40966858)
33. R.H. Boger, S.M. Bode-Boger, and A. Szuba Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia Circulation 98 1998 1842 1847 (Pubitemid 28509278)
34. R.H. Boger The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor Cardiovasc Res 59 2003 824 833 (Pubitemid 38366238)
35. J.P. Cooke Does ADMA cause endothelial dysfunction? Arterioscler Thromb Vasc Biol 20 2000 2032 2037
36. K. Sydow, E. Schwedhelm, and N. Arakawa ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: effects of l-arginine and B vitamins Cardiovasc Res 57 2003 244 252 (Pubitemid 36009457)
37. J.M. Leiper The DDAH-ADMA-NOS pathway Ther Drug Monit 27 2005 744 746 (Pubitemid 44391728)
38. J.E. Deanfield, J.P. Halcox, and T.J. Rabelink Endothelial function and dysfunction: testing and clinical relevance Circulation 115 2007 1285 1295 (Pubitemid 46594773)
39. D.T. Ngo, T. Heresztyn, and K. Mishra Aortic stenosis is associated with elevated plasma levels of asymmetric dimethylarginine (ADMA) Nitric Oxide 16 2007 197 201 (Pubitemid 46149393)
40. L.M. Moura, S.F. Ramos, and J.L. Zamorano Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis J Am Coll Cardiol 49 2007 554 561 (Pubitemid 46177435)
41. T.M. Lu, Y.A. Ding, and H.B. Leu Effect of rosuvastatin on plasma levels of asymmetric dimethylarginine in patients with hypercholesterolemia Am J Cardiol 94 2004 157 161
42. T. Ikeda, K. Matsuda, and H. Itoh Plasma levels of brain and atrial natriuretic peptides elevate in proportion to left ventricular end-systolic wall stress in patients with aortic stenosis Am Heart J 133 1997 307 314
43. M. Weber, R. Arnold, and M. Rau Relation of N-terminal pro B-type natriuretic peptide to progression of aortic valve disease Eur Heart J 26 2005 1023 1030 (Pubitemid 40695033)
44. J. Bergler-Klein, U. Klaar, and M. Heger Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis Circulation 109 2004 2302 2308 (Pubitemid 38678520)
45. G. Cagirci, S. Cay, and A. Canga Association between plasma asymmetrical dimethylarginine activity and severity of aortic valve stenosis J Cardiovasc Med 12 2011 96 101